|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1989; 13:755-763 © 1989 by the American College of Cardiology Foundation |
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
The object of this study was to test the hypothesis that administration of both serotonin S2 and thromboxane A2-prostaglandin H2 (PGH2) receptor antagonists provides significant protection against epinephrine-induced cyclic coronary artery flow variations in open chest, anesthetized dogs with severe proximal coronary artery stenosis and endothelial injury. Three groups of dogs were studied. In Group 1 (n = 7) and Group 2 (n = 6), cyclic coronary flow variations were initiated after placement of a concentric constrictor around the left anterior descending coronary artery and were abolished by administration of either a thromboxane A2-prostaglandin H2 receptor antagonist, SQ29,548 (SQ) (Group 1), or a serotonin S2 receptor antagonist, LY53,857 (LY) (Group 2). Cyclic flow variations were restored with an epinephrine infusion and the second antagonist (LY for Group 1; SQ for Group 2) was administered to abolish epinephrine-induced cyclic flow variations. The rate of epinephrine infusion was increased until cyclic coronary flow variations returned (n = 8) or significant hemodynamic changes occurred. Plasma epinephrine concentrations were determined during a control period of cyclic coronary flow variations, after epinephrine restored cyclic flow variations in the presence of either SQ or LY, and again after epinephrine restored cyclic flow variations in the presence of both SQ and LY. A third group of dogs (Group 3, n = 9) required both SQ and LY to eliminate the initial cyclic coronary flow variations and infused epinephrine restored cyclic flow variations (n = 8). Plasma epinephrine concentrations were determined during a control period and after cyclic coronary flow variation restoration with epinephrine.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  A. W. Ashton, S. Mukherjee, F. Nagajyothi, H. Huang, V. L. Braunstein, M. S. Desruisseaux, S. M. Factor, L. Lopez, J. W. Berman, M. Wittner, et al. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection J. Exp. Med., April 16, 2007; 204(4): 929 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Gibson and A. Schomig Coronary and Myocardial Angiography: Angiographic Assessment of Both Epicardial and Myocardial Perfusion Circulation, June 29, 2004; 109(25): 3096 - 3105. [Full Text] [PDF]
|
|
|
|
|
|
H. V. Anderson, J. McNatt, F. J. Clubb, M. Herman, J.-P. Maffrand, F. DeClerck, C. Ahn, L. M. Buja, and J. T. Willerson Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries Circulation, November 6, 2001; 104(19): 2331 - 2337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zoldhelyi, P. J. Beck, R. J. Bjercke, J. C. Ober, X. Hu, J. M. McNatt, S. Akhtar, M. Ahmed, F. J. Clubb Jr., Z.-Q. Chen, et al. Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3065 - H3075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vikenes, M. Farstad, and J. E. Nordrehaug Serotonin Is Associated with Coronary Artery Disease and Cardiac Events Circulation, August 3, 1999; 100(5): 483 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Minshall, F. Z. Stanczyk, K. Miyagawa, B. Uchida, M. Axthelm, M. Novy, and K. Hermsmeyer Ovarian Steroid Protection against Coronary Artery Hyperreactivity in Rhesus Monkeys J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 649 - 659. [Abstract] [Full Text]
|
|
|
|
|
|
K. Fujise, L. Stacy, P. Beck, E. T.H. Yeh, A. Chuang, T. A. Brock, and J. T. Willerson Differential Effects of Endothelin Receptor Activation on Cyclic Flow Variations in Rat Mesenteric Arteries Circulation, November 18, 1997; 96(10): 3641 - 3646. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ueyama, H. Ikeda, N. Haramaki, K. Kuwano, and T. Imaizumi Effects of Monoclonal Antibody to P-Selectin and Analogue of Sialyl Lewis X on Cyclic Flow Variations in Stenosed and Endothelium-Injured Canine Coronary Arteries Circulation, March 18, 1997; 95(6): 1554 - 1559. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-P. Valentin, S. Vieu, F. Bertolino, P. Fauré, and G. W. John Differential Involvement of Serotonin 2A/C and Thromboxane A2/Prostanoid Receptors in High- vs. Low-Shear Rate Arterial Thrombosis in Rabbits J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 761 - 769. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Biasucci, G. Liuzzo, G. Caligiuri, G. Quaranta, F. Andreotti, G. Sperti, W. van de Greef, A. G. Rebuzzi, C. Kluft, and A. Maseri Temporal Relation Between Ischemic Episodes and Activation of the Coagulation System in Unstable Angina Circulation, June 15, 1996; 93(12): 2121 - 2127. [Abstract] [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
